92
Views
3
CrossRef citations to date
0
Altmetric
Review

Rett syndrome: from recognition to diagnosis to intervention

Pages 327-336 | Published online: 10 Jan 2014

References

  • Guy J, Gan J, Selfridge J et al. Reversal of neurological defects in a mouse model of Rett syndrome. Science315, 1143–1147 (2007).
  • Giacometti E, Luikenhuis S, Beard C, Jaenisch R. Partial rescue of Mecp2 deficiency by postnatal activation of MECP2. Proc. Natl Acad. Sci. USA104, 1931–1936 (2007).
  • MoRetti P, Levenson JM, Battaglia F et al. Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J. Neurosci.26, 319–327 (2006).
  • McGill BE, Bundle SF, Yaylaoglu MB et al. Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome. Proc. Natl Acad. Sci. USA103, 18267–18272 (2006).
  • Hagberg B, Aicardi J, Dias K, Ramos O. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett’s syndrome: report of 35 cases. Ann. Neurol.14, 471–479 (1983).
  • Laurvick CL, de Klerk N, Bower C et al. Rett syndrome in Australia: a review of the epidemiology. J. Pediatr.148, 347–352 (2006).
  • Zoghbi HY, Ledbetter DH, Schultz R et al. A de novo X;3 translocation in Rett syndrome. Am. J. Med. Genet.35, 148–151 (1990).
  • Ellison KA, Fill CP, Terwilliger J et al. Examination of X chromosome markers in Rett syndrome: exclusion mapping with a novel variation on multilocus linkage analysis. Am. J. Hum. Genet.50, 278–287 (1992).
  • Schanen C, Dahle E, Capozzoli F et al. A new Rett syndrome family consistent with X-linked inheritance expands the X chromosome exclusion map. Am. J. Hum. Genet.61, 634–641 (1997).
  • Amir R, Van den Veyver I, Wan M et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet.23, 185–188 (1999).
  • Neul JL, Fang P, Barrish J et al. Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome. Neurology (2008) (In Press).
  • Percy AK, Lane JB, Childers J et al. Rett syndrome: North American database. J. Child Neurol.22, 1338–1341 (2007).
  • Hagberg B, Hanefeld F, Percy A, Skjeldal O. An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden Baden, Germany, 11 September 2001. Eur. J. Paediatr. Neurol.66, 293–297 (2002).
  • Kankirawatana P, Leonard H, Ellaway C et al. Early progressive encephalopathy in boys and MECP2 mutations. Neurology67, 164–166 (2006).
  • Meins M, Lehmann J, Gerresheim F et al. Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome. J. Med. Genet.42, e12 (2005).
  • Van Esch H, Bauters M, Ignatius J et al. Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am. J. Hum. Genet.77, 442–453 (2005).
  • Lugtenberg D, de Brouwer AP, Kleefstra T et al. Chromosomal copy number changes in patients with non-syndromic X linked mental retardation detected by array CGH. J. Med. Genet.43, 362–370 (2006).
  • Friez MJ, Jones JR, Clarkson K et al. Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28. Pediatrics118, e1687–e1695 (2006).
  • del Gaudio D, Fang P, Scaglia F et al. Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males. Genet. Med.8, 784–792 (2006).
  • Villard L. MECP2 mutations in males. J. Med. Genet.44, 417–423 (2007).
  • Schwartzman JS, Bernardino A, Nishimura A et al. Rett syndrome in a boy with a 47,XXY karyotype confirmed by a rare mutation in the MECP2 gene. Neuropediatrics32, 162–164 (2001).
  • Clayton-Smith J, Watson P, Ramsden S, Black G. Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males. Lancet356, 830–832 (2000).
  • Schanen C, Houwink EJ, Dorrani N et al. Phenotypic manifestations of MECP2 mutations in classical and atypical Rett syndrome. Am J. Med. Genet.126A, 129–140 (2004).
  • Bebbington A, Anderson A, Ravine D et al. Investigating genotype–phenotype relationships in Rett syndrome using an international dataset. Neurology70, 868–875 (2008).
  • Tarquinio D, Lane J, Percy A et al. The natural history of Rett syndrome: phenotypic differences in classical Rett syndrome are associated with specific MECP2 mutations. Presented at: Rare Disease Clinical Research Network Conference on Clinical Research for Rare Diseases. Bethesda, MD, USA, 5 September 2007.
  • Schultz RJ, Glaze DG, Motil KJ et al. The pattern of growth failure in Rett syndrome. Am. J. Dis. Child.147, 633–637 (1993).
  • Lidstrom J, Stokland E, Hagberg B. Scoliosis in Rett syndrome. Clinical and biological aspects. Spine19, 1632–1635 (1994).
  • Kerr AM, Webb P, Prescott RJ, Milne Y. Results of surgery for scoliosis in Rett syndrome. J. Child Neurol.18, 703–708 (2003).
  • Motil KJ, Schultz RJ, Abrams S et al. Fractional calcium absorption is increased in girls with Rett syndrome. J. Pediatr. Gastroenterol. Nutr.42, 419–426 (2006).
  • Sekul EA, Moak JP, Schultz RJ et al. Electrocardiographic findings in Rett syndrome: an explanation for sudden death? J. Pediatr.125, 80–82 (1994).
  • Percy AK Lane JB. Rett syndrome: clinical and molecular update. Curr. Opin. Pediatr.16, 670–677 (2004).
  • Percy A, Dragich J, Schanen N. Rett syndrome: clinical–molecular correlates. In: Genetics and Genomics of Neurobehavioral Disorders. Fisch G (Ed.). Humana Press Inc., NJ, USA 391–418 (2003).
  • Schultz R, Glaze D, Motil K et al. Hand and foot growth failure in Rett syndrome. J. Child Neurol.13, 71–74 (1998).
  • Glaze D, Schultz R, Frost J. Rett syndrome: characterization of seizures and non-seizures. Electroencephalogr. Clin. Neurophysiol.106, 79–83 (1998).
  • Glaze D, Frost J, Zoghbi H, Percy A. Rett’s syndrome: characterization of respiratory patterns and sleep. Ann. Neurol.21, 377–382 (1987).
  • Percy AK, Glaze DG, Schultz RJ et al. Rett syndrome: controlled study of an oral opiate antagonist, naltrexone. Ann. Neurol.35, 464–470 (1994).
  • Motil KJ, Schultz RJ, Browning K et al. Oropharyngeal dysfunction and gastroesophageal dysmotility are present in girls and women with Rett syndrome. J. Pediatr. Gastroenterol. Nutr.29, 31–37 (1999).
  • Motil K, Shultz R, Wong W, Glaze D. Increased energy expenditure associated with repetitive involuntary movement does not contribute to growth failure in girls with Rett syndrome. J. Pediatr.132, 228–233 (1998).
  • FitzGerald PM, Jankovic J, Percy AK. Rett syndrome and associated movement disorders. Mov. Disord.5, 195–202 (1990).
  • Pelka GJ, Watson CM, Radziewic T et al.MECP2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice. Brain129(4), 887–898 (2006).
  • Chang Q, Khare G, Dani V et al. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron49, 341–348 (2006).
  • Wang H, Chan SA, Ogier M et al. Dysregulation of brain-derived neurotrophic factor expression and neurosecretory function in Mecp2 null mice. J. Neurosci.26, 10911–10915 (2006).
  • Viemari JC, Roux JC, Tryba AK et al. Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice. J. Neurosci.25, 11521–11530 (2005).
  • Roux JC, Dura E, Moncla A et al. Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome. Eur. J. Neurosci.25, 1915–1922 (2007).
  • Metcalf BM, Mullaney BC, Johnston MV, Blue ME. Temporal shift in methyl-CpG binding protein 2 expression in a mouse model of Rett syndrome. Neuroscience139, 1449–1460 (2006).
  • Paterson DS, Thompson EG, Belliveau RA et al. Serotonin transporter abnormality in the dorsal motor nucleus of the vagus in Rett syndrome: potential implications for clinical autonomic dysfunction. J. Neuropathol. Exp. Neurol.64, 1018–1027 (2005).
  • Itoh M, Ide S, Takashima S et al. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains. J. Neuropathol. Exp. Neurol.66, 117–123 (2007).
  • Ben-Schachar S, MoRetti P, Fyffe S et al. Avp is altered in mouse models of Rett syndrome and related MECP2 disorders and is a transcriptional target of MeCP2. Presented at:Rare Disease Clinical Research Network Conference on Clinical Research Conference. Bethesda, MD, USA, 5 September 2007.
  • Budden SS. Rett syndrome: habilitation and management reviewed. Eur. Child Adolesc. Psychiatry6, 103–107 (1997).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.